Shore, Susan E.
Roberts, Larry E.
Langguth, Berthold
Article History
First Online: 12 February 2016
Competing interests
: B.L. has received honoraria for speaking and consultancy from ANM, AstraZeneca, Autifony, Gerson Lehrman Group, Lundbeck, McKinsey, Merz, Magventure, Novartis, Neuromod Devices, Pfizer and Servier, grants and research support from AstraZeneca, Cerbomed, Deymed, Magventure, Sivantos and Otonomy, and travel and accommodation payments from Lilly, Servier and Pfizer. B.L. holds patents for the use of neuronavigation for transcranial magnetic stimulation and for the use of cyclobenzaprine for tinnitus treatment. The other authors declare no competing interests.